Form 8-K - Current report:
SEC Accession No. 0001664710-24-000031
Filing Date
2024-03-06
Accepted
2024-03-06 08:01:41
Documents
65
Period of Report
2024-03-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kros-20240306.htm   iXBRL 8-K 36755
2 EX-99.1 corporatepresentation.htm EX-99.1 63968
6 corporatepresentation001.jpg GRAPHIC 78942
7 corporatepresentation002.jpg GRAPHIC 269811
8 corporatepresentation003.jpg GRAPHIC 160197
9 corporatepresentation004.jpg GRAPHIC 64664
10 corporatepresentation005.jpg GRAPHIC 149587
11 corporatepresentation006.jpg GRAPHIC 85691
12 corporatepresentation007.jpg GRAPHIC 104912
13 corporatepresentation008.jpg GRAPHIC 145278
14 corporatepresentation009.jpg GRAPHIC 152637
15 corporatepresentation010.jpg GRAPHIC 147757
16 corporatepresentation011.jpg GRAPHIC 127421
17 corporatepresentation012.jpg GRAPHIC 119698
18 corporatepresentation013.jpg GRAPHIC 111240
19 corporatepresentation014.jpg GRAPHIC 111805
20 corporatepresentation015.jpg GRAPHIC 134261
21 corporatepresentation016.jpg GRAPHIC 165571
22 corporatepresentation017.jpg GRAPHIC 149834
23 corporatepresentation018.jpg GRAPHIC 108650
24 corporatepresentation019.jpg GRAPHIC 111409
25 corporatepresentation020.jpg GRAPHIC 160460
26 corporatepresentation021.jpg GRAPHIC 123530
27 corporatepresentation022.jpg GRAPHIC 134592
28 corporatepresentation023.jpg GRAPHIC 84808
29 corporatepresentation024.jpg GRAPHIC 96351
30 corporatepresentation025.jpg GRAPHIC 164270
31 corporatepresentation026.jpg GRAPHIC 120206
32 corporatepresentation027.jpg GRAPHIC 147426
33 corporatepresentation028.jpg GRAPHIC 138820
34 corporatepresentation029.jpg GRAPHIC 123275
35 corporatepresentation030.jpg GRAPHIC 131596
36 corporatepresentation031.jpg GRAPHIC 69618
37 corporatepresentation032.jpg GRAPHIC 154328
38 corporatepresentation033.jpg GRAPHIC 76707
39 corporatepresentation034.jpg GRAPHIC 152110
40 corporatepresentation035.jpg GRAPHIC 137527
41 corporatepresentation036.jpg GRAPHIC 95356
42 corporatepresentation037.jpg GRAPHIC 108833
43 corporatepresentation038.jpg GRAPHIC 140434
44 corporatepresentation039.jpg GRAPHIC 133070
45 corporatepresentation040.jpg GRAPHIC 150889
46 corporatepresentation041.jpg GRAPHIC 118142
47 corporatepresentation042.jpg GRAPHIC 127441
48 corporatepresentation043.jpg GRAPHIC 111044
49 corporatepresentation044.jpg GRAPHIC 132956
50 corporatepresentation045.jpg GRAPHIC 99020
51 corporatepresentation046.jpg GRAPHIC 124635
52 corporatepresentation047.jpg GRAPHIC 83022
53 corporatepresentation048.jpg GRAPHIC 78633
54 corporatepresentation049.jpg GRAPHIC 115081
55 corporatepresentation050.jpg GRAPHIC 75269
  Complete submission text file 0001664710-24-000031.txt   8807963

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kros-20240306.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kros-20240306_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kros-20240306_pre.xml EX-101.PRE 13046
66 EXTRACTED XBRL INSTANCE DOCUMENT kros-20240306_htm.xml XML 2823
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39264 | Film No.: 24724410
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)